tiprankstipranks
Estrella Immunopharma (ESLA)
NASDAQ:ESLA
US Market
ESLA
Estrella Immunopharma
RESEARCH TOOLSreports

Estrella Immunopharma (ESLA) Financial Statements

38 Followers

Estrella Immunopharma Financial Overview

Estrella Immunopharma's market cap is currently $81.92M. The company's EPS TTM is $-0.243; its P/E ratio is -4.40; Estrella Immunopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Jun 24Dec 22Jun 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -13.06M$ -8.85M$ -7.31M$ -1.57M$ -1.69M
EBITDA$ -13.06M$ -8.85M$ -7.31M$ -686.97K$ -11.16K
Net Income$ -13.06M$ -8.85M$ -7.31M$ -996.10K$ -1.69M
Balance Sheet
Cash & Short-Term Investments$ 1.38M$ 916.92K$ 4.17M$ 40.80K$ 4.09M
Total Assets$ 3.18M$ 3.14M$ 4.45M$ 9.99M$ 4.92M
Total Debt$ 0.00$ 0.00$ 0.00$ 498.60K$ 0.00
Net Debt$ -1.38M$ -916.92K$ -4.17M$ 457.80K$ -4.09M
Total Liabilities$ 13.54M$ 3.00M$ 180.70K$ 2.92M$ 5.96M
Stockholders' Equity$ -10.37M$ 143.73K$ 4.27M$ 7.07M$ -1.04M
Cash Flow
Free Cash Flow$ -1.79M$ -7.64M$ -16.07M$ -1.04M$ -1.44M
Operating Cash Flow$ -1.79M$ -7.64M$ -16.07M$ -1.04M$ -1.44M
Investing Cash Flow$ 0.00$ 0.00$ 4.96M$ 36.17M$ -45.19M
Financing Cash Flow$ 2.25M$ -489.43K$ 12.79M$ -35.56M$ 5.53M
Currency in USD

Estrella Immunopharma Earnings and Revenue History

Income Statement >

Estrella Immunopharma Debt to Assets

Balance Sheet >

Estrella Immunopharma Cash Flow

Cash Flow >

Estrella Immunopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >